limb girdle muscular dystrophy 1F (LGMD1F) - News, Articles, Whitepapers - Drug Target Review

Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseases

Limb-Girdle Muscular Dystrophy Scientific Leaders - Together With the FDA - Will Come Together for a Drug Development Workshop on February 8, 2024

Cells, Free Full-Text

limb girdle muscular dystrophy 1F (LGMD1F) - News, Articles, Whitepapers - Drug Target Review

Limb-girdle muscular dystrophies — international collaborations for translational research

Third International Limb Girdle Muscular Dystrophy Conference to Be Held in Washington, D.C. On October 27-29, 2023

The muscular dystrophies (Chapter 11) - Neurogenetics

Muscles, Free Full-Text

Limb-Girdle Muscular Dystrophy Externally-Led Patient-Focused Drug Development (EL-PFDD)

Facioscapulohumeral muscular dystrophy - Wikipedia

Frontiers Preliminary Evidences of Safety and Efficacy of Flavonoids- and Omega 3-Based Compound for Muscular Dystrophies Treatment: A Randomized Double-Blind Placebo Controlled Pilot Clinical Trial

Limb-Girdle Muscular Dystrophy Leaders Advance Collaborative Dialogue to Accelerate Drug Development to Address the Urgent Unmet Need in Limb-Girdle Muscular Dystrophy

Third International Limb Girdle Muscular Dystrophy Conference to Be Held in Washington, D.C. On October 27-29, 2023

Identification of thiostrepton as a pharmacological approach to rescue misfolded alpha-sarcoglycan mutant proteins from degradation